Skip to main content

Peer Review reports

From: Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice

Original Submission
7 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
27 Jan 2022 Reviewed Reviewer Report
10 Feb 2022 Reviewed Reviewer Report
18 Feb 2022 Author responded Author comments - Takaya Yamamoto
Resubmission - Version 3
18 Feb 2022 Submitted Manuscript version 3
22 Feb 2022 Reviewed Reviewer Report
28 Feb 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
2 Mar 2022 Editorially accepted
4 Apr 2022 Article published 10.1186/s12885-022-09354-1

You can find further information about peer review here.

Back to article page